If fully approved, it would be the first drug to slow cognitive decline in people living with the disease and the first new treatment for Alzheimer’s in nearly 20 years. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.